Follow-up of human adenovirus viral load in pediatric hematopoietic stem cell transplant recipients.

Plasma HAdV-DNA positivity is a potential influencer that decreases survival in the early post-transplant period. Due to the high mortality rates, close monitoring is required of HAdV infections after HSCT with sensitive methods, especially at the early stage.